BRONCHIAL THERMOPLASTY

Do you take your daily asthma medication as prescribed by your doctor and still have at least 2 or more asthma attacks a year that require you to take Prednisone for those attacks? 

  

If so, your asthma may be considered in the severe category by global asthma guidelines. Bronchial Thermoplasty (BT) is included as an option for adult patients with severe asthma still symptomatic despite Inhaled Corticosteroids and Long Acting Beta Agonists.


Bronchial Thermoplasty delivered by the Alair™ BT System from Boston Scientific, is a minimally invasive procedure that may be an option for patients 18 years or older who suffer from severe and persistent asthma that is not well controlled with inhaled corticosteroids and long-acting beta-agonists. These patients may take multiple asthma medications, suffer from asthma attacks, and may be adjusting their lifestyle around their asthma symptoms.


  

About the BT Procedure 

With no incision needed, BT is performed with a bronchoscope inserted through the nose or mouth and mild heat is delivered to the smooth muscle of the airway in the lungs, reducing the excessive smooth muscle.



Proven to last at least 5 Years 

The Alair System is proven to be clinically safe and effective with results confirmed to last at least 5 years. BT reduces the smooth muscle, allowing the airways to constrict less and making breathing easier by decreasing severe asthma attacks. BT is also clinically proven to reduce the amount of ER visits by 84% and decrease severe exacerbations by 32%.



Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: 

The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms.


  

It’s About Breathing 

Connect with a community of severe asthma patients who took back their lives by taking control of their asthma with the help of the BT procedure by visiting: 

https://www.itsaboutbreathing.com/s/



Sources 

1.Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA)2015. May 19, 2015

2.Castro M, et al, for the AIR2 Trial Study Group. Am J Respir Crit Care Med. 2010;181:116-124.

These statements are examples. Be sure to consult with your regulatory professionals before using. Results from case studies are not predictive of results in other cases. Results in other cases may vary. All trademarks are the property of their respective owners.

Indications, Contraindications, Warnings and Instructions for Use can be found in the product labeling supplied with each device. 

CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. 

©2017 Boston Scientific Corporation or its affiliates. All rights reserved. 

ENDO-484303-AA August 2017

image3
image4

image5

Bronchial Thermoplasty Animation Video